2-Styrylchromones Modulate Prostaglandins Production through the Inhibition of COX-2 †
by
, , , and
Mariana Lucas
1,
Marisa Freitas
1,
Artur M. S. Silva
2,
Eduarda Fernandes
1,* and
Daniela Ribeiro
1,3,* 1
LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
2
LAQV, REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
3
Faculty of Agrarian Sciences and Environment, University of the Azores, 9700-042 Angra do Heroísmo, Portugal
*
Authors to whom correspondence should be addressed.
†
Presented at the 8th International Electronic Conference on Medicinal Chemistry, 1–30 November 2022; Available online: https://ecmc2022.sciforum.net/ .
Med. Sci. Forum 2022, 14(1), 94; https://doi.org/10.3390/ECMC2022-13232
Published: 1 November 2022
(This article belongs to the Proceedings of The 8th International Electronic Conference on Medicinal Chemistry)
Abstract
:2-Styrylchromones (2-SC) are heterocyclic compounds with a structure of at least 17 carbons and a styryl group attached to a benzoannelated γ-pyrone ring. Although the anti-inflammatory potential of 2-SC has become a subject of interest, their effects in inflammatory pathways are still unexplored. Therefore, to better understand the mechanisms of anti-inflammatory action of 2-SC, this study investigated the influence of 10 hydroxylated and methoxylated 2-SC on the inhibitory activity of cyclooxygenase (COX-2), through an in vitro non-cellular assay and an ex vivo assay in human whole blood, which were based on the fluorometric detection of prostaglandin (PG) G2 and colorimetric detection of PGE2, respectively. A 2-SC hydroxylated at C-7 and C-8 on the A-ring and C-3′ and C-4′ on the B-ring was the most active in the direct inhibition of COX-2 activity, whereas a 2-SC methoxylated at C-4′ on the B-ring was the most active in the ex vivo inhibition of PGE2 production. The obtained results suggest that the presence of OH groups, especially at C-8 on the A-ring, favor the direct inhibition of COX-2. Conversely, for inhibition of PGE2 production in a more complex matrix, human blood, it is the presence of an OCH3 at C-4′ on the B-ring that seems to be important.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/ECMC2022-13232/s1.
Author Contributions
Conceptualization, E.F. and D.R.; methodology, M.L.; validation, E.F. and D.R.; formal analysis, M.L.; investigation, M.L.; writing—original draft preparation, M.L.; writing—review and editing, M.L., M.F., A.M.S.S., E.F. and D.R.; supervision, A.M.S.S., E.F. and D.R.; project administration, E.F. and D.R.; funding acquisition, E.F. and D.R. All authors have read and agreed to the published version of the manuscript.
Funding
This work received support from PT national funds (FCT/MCTES, Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior) through the projects UIDB/50006/2020 and UIDP/50006/2020. Authors acknowledge the European Union [FEDER funds through the Operational Competitiveness Program (COMPETE2020) PO-CI-01-0145-FEDER-029253-Project PTDC/MED-QUI/29253/2017]. ML thanks FCT/MCTES and ESF (European Social Fund) through NORTE 2020 (Programa Operacional Região Norte) for her PhD grant (ref. 2021.06746.BD). MF acknowledges her contract under the CEEC Individual (2020.04126.CEECIND/CP1596/CT0006) and also thanks LAQV/REQUIMTE for her contract under the reference LA/P/0008/2020.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Centro Hospitalar Univesitário do Porto/Instituto de Ciências Biomédicas Abel Salazar, Oporto, Portugal.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Lucas, M.; Freitas, M.; Silva, A.M.S.; Fernandes, E.; Ribeiro, D. 2-Styrylchromones Modulate Prostaglandins Production through the Inhibition of COX-2. Med. Sci. Forum 2022, 14, 94. https://doi.org/10.3390/ECMC2022-13232
AMA Style
Lucas M, Freitas M, Silva AMS, Fernandes E, Ribeiro D. 2-Styrylchromones Modulate Prostaglandins Production through the Inhibition of COX-2. Medical Sciences Forum. 2022; 14(1):94. https://doi.org/10.3390/ECMC2022-13232
Chicago/Turabian StyleLucas, Mariana, Marisa Freitas, Artur M. S. Silva, Eduarda Fernandes, and Daniela Ribeiro. 2022. "2-Styrylchromones Modulate Prostaglandins Production through the Inhibition of COX-2" Medical Sciences Forum 14, no. 1: 94. https://doi.org/10.3390/ECMC2022-13232
